Gerry Brunk

Gerry Brunk is the Managing Director at Lumira Ventures. They currently serve on the boards of Cyrano Therapeutics, Corvia Medical, Endogenex, enGene, HistoSonics, SpectraWAVE, PIC Therapeutics, Cadence Neuroscience, GenEp, and Southeast Life Sciences, and participate in the UVA Seed Fund Advisory Committee. They previously served on the board of Endotronix from 2016 to 2024, and held other governance roles including Bardy Diagnostics (board observer, 2019–2021), Engage Therapeutics (board of directors, 2017–2020), Pharmasset (board of directors, 2004–2007), MAKO Surgical Corp. (board of directors, 2004–2009), Cardiac Dimensions (board of directors, 2007–2019), and ActiveCyte (Chief Operating Officer, 2000–2002). They are pursuing an MBA at Stanford University Graduate School of Business.